Chronic Low Back Pain Treatment Market Report 2024 (Global Edition)

Global Chronic Low Back Pain Treatment Market Report 2024 Market Size Split by Drug Class (Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, Others), by Route of Administrati...

Chronic Low Back Pain Treatment Market Report Description

We have various report editions of Chronic Low Back Pain Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Chronic Low Back Pain Treatment Market Insights Video

Competitive Landscape of the Chronic Low Back Pain Treatment Market

The competitive landscape of the Chronic Low Back Pain (CLBP) treatment market features a diverse array of players, including pharmaceutical companies offering analgesics and anti-inflammatories, medical device firms providing spinal implants and braces, and digital health companies focusing on telemedicine and virtual physiotherapy. Key competitors invest in research and development to innovate treatment options and improve efficacy. Market dynamics are influenced by technological advancements, regulatory changes, and the increasing demand for integrated, patient-centered care solutions.

In August 2023, A clinical-stage biopharmaceutical business called NRx Pharmaceuticals, Inc. submitted an IND application to the FDA in the United States for the use of NRX-101 as a treatment for chronic pain. Utilizing D-cycloserine, a crucial component of NRX-101, as a therapy for chronic pain, the IND application makes use of cutting-edge research in this area. (Source: https://www.nrxpharma.com/nrx-pharmaceuticals-investigational-new-drug-ind-application-for-nrx-101-in-the-treatment-of-complicated-urinary-tract-infections/) In June 2023, The Horizon PRO range of lower spine braces was introduced by Aspen Medical Products (Aspen), a leader in the field of mobility and pain management solutions, with the goal of reducing symptoms associated with lower back pain brought on by muscular strain and spasms. With Aspen's scientifically proven tri-band technology, the Horizon PRO series offers an improved method of pain treatment. This inelastic design, which is supported by research, increases trunk stability to lessen the strain on overworked muscles, which is important for alleviating excruciating lower back discomfort. (Source: https://www.aspenmp.com/blogs/news/aspen-medical-products-expands-pain-management-solutions-with-the-launch-of-the-horizon-pro-line) In February 2022, Scilex Holding Company announced complete enrollment in Phase 2, a randomized, double-blind, placebo-controlled, parallel-group, multicenter study for evaluating the safety and efficacy of SP-103 (lidocaine topical system) 5.4% triple-strength formulation for ZTlido, in subjects with acute Lower Back Pain. (Source: https://www.scilexholding.com/archives/2021)

Top Companies Market Share in Chronic Low Back Pain Treatment Industry: (In no particular order of Rank)

• Pfizer
• Inc.
• Lilly
• GSK plc
• Johnson & Johnson Services
• Inc.
• Merck & Co
• Inc.
• Sanofi
• Novartis AG
• Dr. Reddy’s Laboratories Ltd.
• Bayer AG
• Endo International plc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Chronic Low Back Pain Treatment Market

Which Region Dominates the Chronic Low Back Pain Treatment Market in 2024?

According to Cognitive Market Research, North America currently dominates the Chronic Low Back Pain Treatments market due to modern healthcare infrastructure, high healthcare expenditure, and a strong emphasis on research and innovation. The region benefits from the high prevalence of chronic pain conditions and the widespread adoption of both traditional and emerging treatment modalities.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period due to the rising prevalence of back pain, increasing healthcare access, and growing awareness of advanced treatment options. Rapid economic development and expanding healthcare infrastructure further drive market growth in the region.

The current report Scope analyzes Chronic Low Back Pain Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Chronic Low Back Pain Treatment Market

According to Cognitive Market Research, the global Chronic Low Back Pain Treatment market size was estimated at USD 2351.2 Million, out of which North America held the major market share of more than 40% of global revenue with a market size of USD 940.48 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 8.0% from the year 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Chronic Low Back Pain Treatment market with a market size of USD 742.04 million in 2024 and is foreseen to rise at the CAGR of 7.8% during the forecast years due to the growing demand for non-invasive treatment options.
• The Canada Chronic Low Back Pain Treatment market had a market share of USD 112.86 million in 2024 and is foreseen to rise at the CAGR of 8..8% during the forecast years due to a growing focus on personalized and non-invasive treatment options.
• The Mexico Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 8.5% during the forecast period, with a market size of USD 85.58 million in 2024.

Europe Chronic Low Back Pain Treatment Market

According to Cognitive Market Research, the global Chronic Low Back Pain Treatment market size was estimated at USD 2351.2 Million, out of which Europe held the market share of more than 30% of global revenue with a market size of USD 705.36 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 8.3% from the year 2024 to 2031.

• The United Kingdom Chronic Low Back Pain Treatment market had a market share of USD 118.50 million in 2024 and is foreseen to rise at the CAGR of 9.1% during the forecast period. In the UK, Chronic Low Back Pain Treatment sales witness an upswing due to the increasing awareness of pain management options.
• The France Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 7.5% during the forecast years, with a market size of USD 64.89 million in 2024.
• According to Cognitive Market Research, the German Chronic Low Back Pain Treatment market size was valued at USD 139.66 million in 2024 and is foreseen to rise at the CAGR of 8.5% during the forecast years. In Germany, Chronic Low Back Pain Treatment surged due to the advancements in medical technologies.
• The Italy Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 7.7% during the forecast years, with a market size of USD 60.66 million in 2024.
• The Russia Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 7.3% during the forecast years, with a market size of USD 109.33 million in 2024.
• The Spain Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 7.4% during the forecast years with a market size of USD 57.84 million in 2024
• The Luxembourg Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 8.4% during the forecast years, with a market size of USD 21.87 million in 2024.
• The Portugal Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 8.1% during the forecast period, with a market size of USD 14.81 million in 2024.
• The Greece Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 8.6% during the forecast period, with a market size of USD 8.46 million in 2024.
• The Rest of Europe's Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 7.0% during the forecast years, with a market size of USD 109.33 million in 2024.

Asia Pacific Chronic Low Back Pain Treatment Market

According to Cognitive Market Research, the global Chronic Low Back Pain Treatment market size was estimated at USD 2351.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with the market size of USD 540.78 million in 2024 and will rise at the compound annual growth rate (CAGR) of 11.8% from the year 2024 to 2031.

• According to Cognitive Market Research, the China Chronic Low Back Pain Treatment market size was valued at USD 243.35 million in 2024 and is foreseen to rise at the CAGR of 11.3% during the forecast years. Chronic Low Back Pain Treatment surged in China due to the surging prevalence of sedentary lifestyles.
• The Japan Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 10.3% during the forecast years, with a market size of USD 74.63 million in 2024.
• The India Chronic Low Back Pain Treatment market had a market share of USD 64.89 million in 2024 and is foreseen to rise at the CAGR of 13.6% during the forecast yearsdue to the rising awareness about pain management solutions .
• The South Korean Chronic Low Back Pain Treatment market is projected to witness growth at a CAGR of 10.9% during the forecast years, with a market size of USD 54.08 million in 2024.
• The Australian Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 11.5% during the forecast years, with a market size of USD 28.12 million in 2024.
• The South East Asia Chronic Low Back Pain Treatment market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 37.31 million in 2024.
• The Rest of Asia Pacific Chronic Low Back Pain Treatment market is projected to witness growth at a CAGR of 11.6% during the forecast years, with a market size of USD 38.40 million in 2024.

South America Chronic Low Back Pain Treatment Market

According to Cognitive Market Research, the global Chronic Low Back Pain Treatment market size was estimated at USD 2351.2 Million, out of which Latin America held the market share of around 5% of global revenue with the market size of USD 117.56 million in 2024 and will rise at the compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Chronic Low Back Pain Treatment market size was valued at USD 50.32 million in 2024 and is foreseen to rise at the CAGR of 9.8% during the forecast years. Chronic Low Back Pain Treatments flourished in Brazil due to the surging prevalence of the musculoskeletal disorders.
• Argentina's Chronic Low Back Pain Treatment market had a market share of USD 19.75 million in the year 2024 and is foreseen to rise at the CAGR of 10.1% during the forecast years due to rising healthcare awareness and access.
• Colombia's Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 9.0% during the forecast years, with a market size of USD 10.46 million in 2024.
• Peru's Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 9.4% during the forecast years, with a market size of USD 9.64 million in 2024.
• Chile's Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 9.5% during the forecast years, with a market size of USD 8.46 million in 2024.
• The Rest of Latin America's Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 8.3% during the forecast years, with a market size of USD 18.93 million in 2024.

Middle East and Africa Chronic Low Back Pain Treatment Market

According to Cognitive Market Research, the global Chronic Low Back Pain Treatment market size was estimated at USD 2351.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 47.02 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 9.5% from 2024 to 2031..

• The GCC Countries Chronic Low Back Pain Treatment market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 20.13 million in 2024. Chronic Low Back Pain Treatment sales flourish due to the growing awareness of pain management options.
• The Egypt Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 9.8% during the forecast period, with a market size of USD 4.94 million in 2024.
• The South Africa Chronic Low Back Pain Treatment market is foreseen to experience growth at a CAGR of 10.5% during the forecast years, with a market size of USD 7.43 million in 2024. Chronic Low Back Pain Treatment sales flourished in South Africa due to the surging prevalence of back pain.
• The Turkey Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 9.0% during the forecast years, with a market size of USD 4.04 million in the year 2024.
• The Nigeria Chronic Low Back Pain Treatment market is foreseen to experience growth at the CAGR of 8.6% during the forecast years, with a market size of USD 4.94 million in 2024.
• The Rest of the MEA Chronic Low Back Pain Treatment market is foreseen to witness growth at the CAGR of 8.5% during the forecast years, with a market size of USD 5.55 million in 2024.

Chronic Low Back Pain Treatment Market Analysis

How are Segments Performing in the Global Chronic Low Back Pain Treatment Market?

Chronic Low Back Pain Treatment Market Drug Class Segment Analysis

According to Cognitive Market Research, non-steroidal anti-inflammatory drugs are likely to dominate the Chronic Low Back Pain Treatment Market over the forecast period due to their effectiveness in minimizing pain and inflammation, broad availability, and relatively low cost compared to other treatments. They are commonly prescribed as the first-line treatment, offering significant relief for many patients while maintaining a favorable safety profile.

The opioid is the fastest-growing segment in the Chronic Low Back Pain Treatment Market due to its potent pain-relieving properties and increasing prescription rates for severe pain management. Despite concerns over addiction, their efficacy in providing rapid and significant relief drives their growth. However, there's a rising emphasis on balancing opioid use with safer, alternative treatments.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Chronic Low Back Pain Treatment Industry. Request a Free Sample PDF!

Chronic Low Back Pain Treatment Market Route of Administration Segment Analysis

According to Cognitive Market Research, the oral segment held the largest revenue share of the market due to its ease of use and effectiveness in managing pain. Over-the-counter and prescription medications, such as analgesics and anti-inflammatory drugs, are widely used for their convenience and immediate relief. Their broad availability and relatively low cost contribute to their dominance in the treatment landscape.

In the Chronic Low Back Pain Treatment Market, the topical sector has been expanding at a rapid pace due to their targeted delivery, minimal systemic side effects, and convenience of use. They offer localized relief through creams, gels, and patches, making them an attractive option for patients seeking effective pain management without the complications associated with oral medications or invasive procedures.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Chronic Low Back Pain Treatment Distribution Channel Segment Analysis

Chronic Low Back Pain Treatment Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the retail & online pharmacies segment holds the largest market share by offering a wide range of over-the-counter medications, pain relief products, and accessible services. Their convenience, competitive pricing, and extensive reach facilitate easy access to treatments, while online platforms enable quick ordering and delivery, expanding market penetration and consumer choice.

In the Chronic Low Back Pain Treatment market, the rapidly growing sector is the hospital pharmacies category due to their direct access to patients with severe or complex cases, ability to offer specialized pain management solutions, and integration with hospital-based treatment plans. Their growth is driven by increased hospital admissions for chronic pain and the demand for tailored, comprehensive care.

• Hospital Pharmacies
• Retail & Online Pharmacies

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion